The video was just reassurance of anecdotal result
Post# of 148170
As far as a rebuttal of the FDA letter from Nader or anyone else. It wasn’t really meant for that response but Nader did touch on the subject and said the letter said nothing different than what was released when when they released the trial results. We know the top line data is the only difference now and we also know the FDA didn’t have the top line data at the time they wrote the letter.
It is nice to see that Dr. Yang is pro Leronlimab still and willing to help progress our Leronlimab. Dr. Nickolas has not lost any faith from the letter and Nader did say he smoothed the road out with all concerned in all the countries that have interest in Leronlimab. It was a long video but reassuring once again the Leronlimab works for critical patients that are high o2 or intubated.